RxDoctor Payments Data

Juhi Lalwani

Physician Assistant · Rockville, MDNPI 1073291126

Payments from drug & device makers

$890in general payments, 2019–2025

Across 35 payments — averaging $25.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$346
  • Pfizer$194
  • Lilly USA, LLC$75
  • Amgen$58
  • AbbVie$58
  • Esperion Therapeutics, Inc.$49
  • plus $111 from 4 others

What the payments were for

  • Food & beverage$890100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$890 in reported general payments places this provider in the 75th percentile of 2,567 physician assistant providers in Maryland.

See all physician assistant providers in Maryland

Medicare billing

Part B allowed, 2024
$22,396
Medicare patients
105
Services billed
253

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban33$56,166
JardianceEmpagliflozin17$18,751
Atorvastatin Calcium165$1,754
Metoprolol Succinate104$1,495
Rosuvastatin Calcium65$1,478
Ezetimibe30$1,257
Losartan Potassium68$880
Nebivolol Hcl13$859
Amlodipine Besylate81$587
ClopidogrelClopidogrel Bisulfate20$517
Albuterol Sulfate HfaAlbuterol Sulfate19$453
Carvedilol35$381
Hydralazine Hcl19$350
Pravastatin Sodium13$315
Lisinopril39$243

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$194$56,16633 claims
Boehringer IngelheimJardiance$22$18,75117 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,567 physician assistant providers in Maryland.

Other physician assistant in Rockville

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →